ResearcherBabu Banarasi Das UniversityActive in the last 2 years
Adil Husain
Matched on ORCID iD 0000-0002-7374-0283; OpenAlex author ID A5060208264. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2026: 3 papers
Papers 3
- Rewiring glucose metabolism in pancreatic cancer by natural compounds: implications for immune evasion and therapeutic targets. Co-author DOI 10.1007/s11033-026-12454-x↗
- Identification and Computational validation of ferroptosis suppressor genes as therapeutic targets in pancreatic cancer. Co-author DOI 10.1007/s12672-026-05269-6↗
- Molecular dissection of pancreatic cancer signaling: Toward targeted therapies for KRAS, MDM2-TP53, EGFR, and PI3K/AKT/mTOR. Last author DOI 10.1016/j.prp.2026.156506↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nitin Kumar Singh · 2 shared papers, 2026 · strength 0.86
- Paper Molecular dissection of pancreatic cancer signaling: Toward targeted therapies for KRAS, MDM2-TP53, EGFR, and PI3K/AKT/… DOI 10.1016/j.prp.2026.156506↗
- Paper Rewiring glucose metabolism in pancreatic cancer by natural compounds: implications for immune evasion and therapeutic … DOI 10.1007/s11033-026-12454-x↗
- Varsha Gupta · 2 shared papers, 2026 · strength 0.65
- Paper Rewiring glucose metabolism in pancreatic cancer by natural compounds: implications for immune evasion and therapeutic … DOI 10.1007/s11033-026-12454-x↗
- Paper Identification and Computational validation of ferroptosis suppressor genes as therapeutic targets in pancreatic cancer. DOI 10.1007/s12672-026-05269-6↗
- Siddhartha Kumar Mishra · 2 shared papers, 2026 · strength 0.65
- Paper Rewiring glucose metabolism in pancreatic cancer by natural compounds: implications for immune evasion and therapeutic … DOI 10.1007/s11033-026-12454-x↗
- Paper Identification and Computational validation of ferroptosis suppressor genes as therapeutic targets in pancreatic cancer. DOI 10.1007/s12672-026-05269-6↗
- Nitin Kumar Singh · 1 shared paper, 2026 · strength 0.29
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.